BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9593120)

  • 1. Modulation of gyrase-mediated DNA cleavage and cell killing by ATP.
    Li TK; Liu LF
    Antimicrob Agents Chemother; 1998 May; 42(5):1022-7. PubMed ID: 9593120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
    Nakada N; Gmünder H; Hirata T; Arisawa M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA unknotting activity (DNA topoisomerase II) isolated from a thermophilic archaebacterium Sulfolobus is inhibited by novobiocin. Partial purification, identification of the two subunits and characteristics of the enzyme.
    Assairi LM
    Biochim Biophys Acta; 1994 Sep; 1219(1):107-14. PubMed ID: 8086447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA gyrase on the bacterial chromosome. Oxolinic acid-induced DNA cleavage in the dnaA-gyrB region.
    Franco RJ; Drlica K
    J Mol Biol; 1988 May; 201(1):229-33. PubMed ID: 2843645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between coumarin drugs and DNA gyrase.
    Maxwell A
    Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phytotoxin albicidin is a novel inhibitor of DNA gyrase.
    Hashimi SM; Wall MK; Smith AB; Maxwell A; Birch RG
    Antimicrob Agents Chemother; 2007 Jan; 51(1):181-7. PubMed ID: 17074789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial DNA supercoiling and [ATP]/[ADP] ratio: changes associated with salt shock.
    Hsieh LS; Rouviere-Yaniv J; Drlica K
    J Bacteriol; 1991 Jun; 173(12):3914-7. PubMed ID: 1646791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of the new quinolones: new data.
    Hooper DC; Wolfson JS
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):223-31. PubMed ID: 1650698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. recF-dependent induction of recA synthesis by coumermycin, a specific inhibitor of the B subunit of DNA gyrase.
    Smith CL
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2510-3. PubMed ID: 6302690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
    Neumann S; Quiñones A
    J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
    Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
    Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC; Shahied SI
    Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
    Kranz RG; Beckman DL; Foster-Hartnett D
    FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy coupling in DNA gyrase and the mechanism of action of novobiocin.
    Sugino A; Higgins NP; Brown PO; Peebles CL; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4838-42. PubMed ID: 368801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase.
    Contreras A; Maxwell A
    Mol Microbiol; 1992 Jun; 6(12):1617-24. PubMed ID: 1323022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atp-bound topoisomerase ii as a target for antitumor drugs.
    Wang H; Mao Y; Zhou N; Hu T; Hsieh TS; Liu LF
    J Biol Chem; 2001 May; 276(19):15990-5. PubMed ID: 11278845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
    Hsu YH; Chung MW; Li TK
    Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.